Hepatocellular carcinoma immune prognosis score predicts the clinical outcomes of hepatocellular carcinoma patients receiving immune checkpoint inhibitors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Hepatocellular carcinoma immune prognosis score predicts the clinical outcomes of hepatocellular carcinoma patients receiving immune checkpoint inhibitors ; volume:23 ; number:1 ; day:1 ; month:12 ; year:2023 ; pages:1-16 ; date:12.2023
BMC cancer ; 23, Heft 1 (1.12.2023), 1-16, 12.2023
- Creator
-
Zhang, Rujia
Zhao, Haoran
Wang, Peng
Guo, Zuoming
Liu, Chunxun
Qu, Zhaowei
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-023-11678-5
- URN
-
urn:nbn:de:101:1-2024022110014940644804
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhang, Rujia
- Zhao, Haoran
- Wang, Peng
- Guo, Zuoming
- Liu, Chunxun
- Qu, Zhaowei
- SpringerLink (Online service)
Other Objects (12)
Immune cell therapy for hepatocellular carcinoma
Pan-cancer analysis of SYNGR2 with a focus on clinical implications and immune landscape in liver hepatocellular carcinoma
Two predictive precision medicine tools for hepatocellular carcinoma
Comparison of immune profiles between hepatocellular carcinoma subtypes
Prognostic role of immune cells in hepatocellular carcinoma
The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma
Prognosis factors of predicting survival in spontaneously ruptured hepatocellular carcinoma
Toward a better understanding of hepatocellular carcinoma immune infiltrates
The immune contexture of hepatocellular carcinoma predicts clinical outcome
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Hepatocellular Carcinoma
Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
Immune cell therapy for hepatocellular carcinoma
Pan-cancer analysis of SYNGR2 with a focus on clinical implications and immune landscape in liver hepatocellular carcinoma
Two predictive precision medicine tools for hepatocellular carcinoma
Comparison of immune profiles between hepatocellular carcinoma subtypes
Prognostic role of immune cells in hepatocellular carcinoma
The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma
Prognosis factors of predicting survival in spontaneously ruptured hepatocellular carcinoma
Toward a better understanding of hepatocellular carcinoma immune infiltrates
The immune contexture of hepatocellular carcinoma predicts clinical outcome
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Hepatocellular Carcinoma
Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
Immune cell therapy for hepatocellular carcinoma
Pan-cancer analysis of SYNGR2 with a focus on clinical implications and immune landscape in liver hepatocellular carcinoma
Two predictive precision medicine tools for hepatocellular carcinoma
Comparison of immune profiles between hepatocellular carcinoma subtypes
Prognostic role of immune cells in hepatocellular carcinoma
The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma
Prognosis factors of predicting survival in spontaneously ruptured hepatocellular carcinoma
Toward a better understanding of hepatocellular carcinoma immune infiltrates
The immune contexture of hepatocellular carcinoma predicts clinical outcome
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Hepatocellular Carcinoma